Clinical Trial Update: To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Paniculata/A. Chilensis for efficacy and tolerability in upper respiratory tract infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• A. Paniculata/A. Chilensis

Snippet

Sponsor: Vedic Lifesciences Pvt. Ltd. | Conditions: Upper Respiratory Tract Infection | Phase 3 | Status: COMPLETED